-
Genelabs Technologies Announces Sale of Equity in Taiwan-Based Biotechnology Company
-
Sunesis Pharmaceuticals Reports Positive Initial Results From Phase 2 Small Cell Lung Cancer Trial With SNS-595
-
MDS Offers to Acquire Molecular Devices for US$615 Million in Major Expansion of MDS Sciex Business
-
Applied DNA Sciences to Present 'The Power of DNA in Detecting and Defeating Pharmaceutical Counterfeiting' at the Anti-Counterfeiting for Pharmaceuticals Conference
-
iCardiac Technologies Enters Into Cardiac Safety Alliance With Pfizer
-
Select Medical Corporation Signs Agreement to Acquire HealthSouth's Outpatient Rehabilitation Division
-
HealthSouth Reaches Definitive Agreement with Select Medical Corporation to Sell Outpatient Rehabilitation Division for Approximately $245 Million
-
Empi Announces FDA Clearance of Select(TM) TENS Device
-
Center to Advance Palliative Care Launches www.getpalliativecare.org
-
DURECT Signs POSIDUR(TM) Manufacturing Agreement with Hospira
-
Exelixis Appoints Jose Baselga, M.D., a Leading Expert in Oncology Drug Discovery and Development, to its Scientific Advisory Board
-
National Prostate Cancer Coalition Launches Clinical Trial Education Program
-
Ability to Reach Remote Areas Boosts Prospects of Wireless Technology in European Healthcare IT Market
-
QIAGEN Unveils Revolutionary Sample Processing Platform
-
REVISED: Kansas Bioscience Authority Commends Governor Sebelius for Naming Task Force to Advocate the Importance of NBAF for National Safety, Security
-
Exelixis Announces January 31 Webcast of Presentation at the Wachovia 2007 Small and Mid Cap Healthcare Conference
-
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Wachovia Conference
-
BioForce Nanosciences Exceeds 2006 Goal for Shipping Nano eNabler(TM) Printers
-
/K I L L K I L L K I L L -- Kansas Bioscience Authority /
-
Delcath Announces the Resignation of M. S. Koly as Chairman of the Board of Directors
-
Kansas Bioscience Authority Commends Governor Sebelius for Naming Task Force to Advocate the Importance of NBAF for National Safety, Security
-
Edwards Lifesciences to Host Earnings Conference Call on February 5, 2007
-
Microbial Novoteqs Expands Presence, Creates Jobs at CET Life Sciences Center
-
Medicsight Changes Company Name to MGT Capital Investments, Inc.
-
Dalton Pharma Services Announces Successful Completion of Health Canada Inspection
-
Cephalon Changes Quarterly Conference Call Date
-
Evercare of Texas Named Provider of Care Coordination Services for Texas Health and Human Service Commission's Integrated Care Management Program
-
Distinguished Scientific Advisory Board Members Announced to Research the Latest Developments in Inflammation and Auto-Immune Diseases Discoveries
-
Carrington and Mannatech Sign Three-year Supply and Trademark Agreement for Manapol(R) Powder
-
IsoTis Inc Starts Trading on Nasdaq
-
Minnesota Partnership Dedicates Three-Story Genomics Facility
-
AEterna Zentaris Discloses New In Vivo Data for ZEN-012 at the 7th Joint Conference of the AACR and JCA
-
Molecular Devices Introduces Arcturus(XT)(TM) Microdissection Instrument
-
BioVeris Completes Additional Vaccine License
-
Pharsight Reports Fiscal Third Quarter 2007 Results
-
CorVel Corporation Announces Quarterly Earnings Release Webcast
-
AFO Research's Next Generation Specialty Optical Glasses Provide Market Changing Opportunities for Medical, Commercial Laser, and Communications Industries
-
Presentations of Latest Stem Cell Scientific Developments to Highlight Second Day of Next Month's Summit in San Diego
-
Boston Scientific To Webcast Conference Call Discussing Fourth Quarter and 2006 Financial Results
-
Isis Announces Appointment of Jeffrey M. Jonas, M.D. as Executive Vice President
-
Avicena Group CEO Featured in Exclusive Interview With WallSt.net
-
PharmAthene and Healthcare Acquisition Corp. Announce Definitive Merger Agreement
-
Quigley QR-443 Cachexia Compound Demonstrates Dose Response Effectiveness in Second Preliminary Animal Model Study; Oral Dosing of QR-443 Equally Effective to Intra-Peritoneal Administration in Delaying the Progression of Cachexia in Preliminary Tumor Burden Mouse Model
-
Pharsight to Participate at January 24-25, 2007 Forum on Sharing Drug-Disease Models to Improve Development Productivity
-
Avalon Pharmaceuticals Raises $10 Million in Private Placement of Common Stock to Institutional Investors
-
Vanda Pharmaceuticals Announces Exercise of Over-Allotment Option by Underwriters
-
Transgenomic, Inc. Announces Resignation of Director and Appoints New Board Member, Interim Chairman of the Board and Secretary
-
Evotec Wins Key Contracts With Solvay Pharmaceuticals: Fragment-Based Drug Discovery and a Third Extension of the Library Synthesis and Medicinal Chemistry Collaboration
-
Pfizer Animal Health Completes Acquisition of Embrex, Inc.
-
BioMS Medical cleared by FDA to initiate pivotal phase III multiple sclerosis trial
|